乙胺碘呋酮是具有Vaughn Williams抗心律失常药分类中全部四类作用的复合性抗心律失常药物。
本文报导了用乙胺碘呋酮治疗21例顽固性心律失常的临床观察。
This paper presents a clinical study on the use of amiodarone administered orally in treating 21 patients with various cardiac arrhythmias resistant to conventional antiarrhythmic agents.
观察了给大鼠单剂及多剂乙胺碘呋酮（简称胺碘酮）后血清、心肌及脂肪组织药浓度的动态变化，并比较了单剂和多剂给药条件下血浆、心肌药浓度和抗心律失常作用的关系。
Pharmacokinetics of amiodarone levels in serum. heart and adi-pose tissues following single or multiple dosing to rats. as well as its relation-ship to anti-arrhythmic activity, were studied.
应用推荐